SCHEMBL20053726

SCHEMBL20053726

CC(C)(F)CN1CCC(COc2cnc(-c3ccc(C(=O)N4CCCC4)c(F)c3)cn2)CC1

nearest known ligand 0.45

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 4/20 0.45
ALOX5AP P20292 3/20 0.39
FEN1 P39748 3/20 0.39
NR3C1 P04150 3/20 0.39
ATR Q13535 2/20 0.38
DYRK1A Q13627 1/20 0.38
PIK3CA P42336 3/20 0.37
MTOR P42345 3/20 0.37
DGAT1 O75907 2/20 0.37
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
MET P08581 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15538518 0.92 ALOX5AP (0.46) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL15538520 0.92 ALOX5AP (0.46) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL21535164 0.92 GPR119 (0.43) GPR119ALOX5APFEN1ATRDYRK1A
SCHEMBL15539321 0.92 ALOX5AP (0.46) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL15539317 0.90 ALOX5AP (0.44) GPR119ALOX5APFEN1ATRPIK3CA
SCHEMBL15538833 0.90 ALOX5AP (0.44) GPR119ALOX5APFEN1ATRPIK3CA
SCHEMBL15539379 0.90 GPR119 (0.45) GPR119ALOX5APFEN1DYRK1ADGAT1
SCHEMBL20053537 0.89 DYRK1A (0.41) GPR119DYRK1APIK3CAMTORHCRTR1
SCHEMBL20053576 0.88 GPR119 (0.58) GPR119NR3C1
SCHEMBL20053643 0.88 GPR119 (0.43) GPR119NR3C1PIK3CAMTORHCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed